UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Corrigendum to “Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review” [Eur J Cancer 198 (2024) 113471]

European journal of cancer (1990), 2024-04, Vol.201, p.113941-113941

2024

Link zum Volltext

Verfügbarkeit prüfen

Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism

International journal of developmental neuroscience, 2005-04, Vol.23 (2-3), p.171-182

2005

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Treating Fields: A fourth modality in cancer treatment, new practice updates

Critical reviews in oncology/hematology, 2021-12, Vol.168, p.103535-103535, Article 103535

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical complexity of utilizing FGFR inhibitors in cancer therapeutics

Expert opinion on investigational drugs, 2020-12, Vol.29 (12), p.1413-1429

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review

European journal of cancer (1990), 2024-02, Vol.198, p.113471-113471, Article 113471

2024

Link zum Volltext

Verfügbarkeit prüfen

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

The Lancet (British edition), 2023-10, Vol.402 (10409), p.1272-1281

2023

Link zum Volltext

Verfügbarkeit prüfen

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

JNCI : Journal of the National Cancer Institute, 2022-03, Vol.114 (3), p.372-380

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapeutic options for pancreatic ductal adenocarcinoma

Expert opinion on pharmacotherapy, 2022-12, Vol.23 (18), p.2079-2089

2022

Link zum Volltext

Verfügbarkeit prüfen

Primary brain tumors in adults

American family physician, 2008-05, Vol.77 (10), p.1423-1430

2008

Link zum Volltext

Verfügbarkeit prüfen

Unusual presentation of large-cell poorly differentiated neuroendocrine carcinoma of the epiglottis

Journal of clinical oncology, 2010-09, Vol.28 (27), p.e461-e463

2010

Link zum Volltext

Verfügbarkeit prüfen

KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer

Future oncology (London, England), 2021-09, Vol.17 (25), p.3291-3299

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1

Expert opinion on investigational drugs, 2021-10, Vol.30 (10), p.1047-1056

2021

Link zum Volltext

Verfügbarkeit prüfen

Bilateral myelomatous pleural effusion: presentation of two cases

Blood Research, 2016, 51(2), , pp.142-144

2016

Link zum Volltext

Verfügbarkeit prüfen

Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)

Expert opinion on investigational drugs, 2019-07, Vol.28 (7), p.583-592

2019

Link zum Volltext

Verfügbarkeit prüfen

Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma

Expert opinion on investigational drugs, 2022-01, Vol.31 (1), p.1-13

2022

Link zum Volltext

Verfügbarkeit prüfen

Kytococcus schroeteri Bacteremia in a Patient with Hairy Cell Leukemia: A Case Report and Review of the Literature

Case reports in infectious diseases, 2015-01, Vol.2015, p.217307-4

2015

Link zum Volltext

Verfügbarkeit prüfen

Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib-a case report

Journal of gastrointestinal oncology, 2024-02, Vol.15 (1), p.478-484

2024

Link zum Volltext

Verfügbarkeit prüfen

Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database

Journal of gastrointestinal oncology, 2019-10, Vol.10 (5), p.869-877

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III–IV melanoma in phase III trial E1609

Quality of life research, 2023-01, Vol.32 (1), p.183-196

2023

Link zum Volltext

Verfügbarkeit prüfen

Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era

Journal of gastrointestinal oncology, 2017-10, Vol.8 (5), p.789-798

2017

Link zum Volltext

Verfügbarkeit prüfen

A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations

Expert opinion on investigational drugs, 2019-08, Vol.28 (8), p.675-686

2019

Link zum Volltext

Verfügbarkeit prüfen

Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma

Journal of clinical oncology, 2013-04, Vol.31 (11), p.e186-e188

2013

Link zum Volltext

Verfügbarkeit prüfen

An unusual case of autoimmune pancreatitis presenting as pancreatic mass and obstructive jaundice: a case report and review of the literature

Journal of medical case reports, 2011-06, Vol.5 (1), p.253-253, Article 253

2011

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin-Induced Lhermitte Sign. A Case Report and Review of Literature

Clinical colorectal cancer, 2014-12, Vol.13 (4), p.257-259

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(55)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(21)
Oncology
(16)
Middle Aged
(8)
Male
(7)
Pharmacology & Pharmacy
(7)
Female
(6)
Adult
(5)
Adenocarcinoma
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Cancer
(4)
Prognosis
(4)
Adolescent
(3)
Aged
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Case Report
(3)
Chemotherapy
(3)
Clinical Trials
(3)
Diagnosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Corrigendum to “Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review” [Eur J Cancer 198 (2024) 113471]

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism

Tumor-Treating Fields: A fourth modality in cancer treatment, new practice updates

Clinical complexity of utilizing FGFR inhibitors in cancer therapeutics

Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

Pharmacotherapeutic options for pancreatic ductal adenocarcinoma

Primary brain tumors in adults

Unusual presentation of large-cell poorly differentiated neuroendocrine carcinoma of the epiglottis

KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer

Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1

Bilateral myelomatous pleural effusion: presentation of two cases

Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)

Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma

Kytococcus schroeteri Bacteremia in a Patient with Hairy Cell Leukemia: A Case Report and Review of the Literature

Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib-a case report

Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database

Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III–IV melanoma in phase III trial E1609

Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era

A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations

Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma

An unusual case of autoimmune pancreatitis presenting as pancreatic mass and obstructive jaundice: a case report and review of the literature

Oxaliplatin-Induced Lhermitte Sign. A Case Report and Review of Literature

Suchergebnisse filtern